REFERENCES
- Huff J., Boyd J., Barrett J. C. Cellular and Molecular Mechanisms of Hormone Carcinogenesis: Environmental Influences. Wiley–Liss, New York 1996
- Newbold R. R., McLachlan J. A. Transplacental hormonal carcinogenesis: Diethylstilbestrol as an example. Prog. Clin. Biol. Res. 1996; 394: 131–147
- Li S., Washburn K. A., Moore R., Uno T., Teng C., Newbold R. R., McLachlan J. A., Negishi M. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res. 1997; 57: 4356–4359
- Boyd J., Takahashi H., Waggoner S. E., Jones L. A., Hajek R. A., Wharton J. T., Liu F. -s., Fujino T., Barrett J. C., McLachlan J. A. Molecular genetic analysis of clear cell adenocarcinomas of the vagina and cervix associated and unassociated with diethylstilbestrol exposure in utero. Cancer 1996; 77: 507–513
- Newbold R. R., Hanson R. B., Jefferson W. N., Bullock B. C., Haseman J., McLachlan J. A. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 1998; 19: 1655–1663
- Barrett J. C., Tsutsui T. Mechanisms of estrogen-associated carcinogenesis. Prog. Clin. Biol. Res. 1996; 394: 101–111
- Hayashi N., Hasegawa K., Komine A., Tanaka Y., McLachlan J. A., Barrett J. C. Estrogen-induced cell transformation and adduct formation in cultured Syrian hamster embryo cells. Mol. Carcinogen. 1996; 16: 149–156
- Tsutsui T., Maizumi H., McLachlan J. A., Barrett J. C. Aneuploidy induction and cell transformation by diethylstilbestrol: A possible chromosomal mechanism in carcinogenesis. Cancer Res. 1983; 43: 3814–3821
- Tucker R. W., Barrett J. C. Decreased numbers of spindle and cytoplasmic microtubules in hamster embryo cells treated with a carcinogen, diethylstilbestrol. Cancer Res. 1986; 46: 2088–2095
- Dunn S. E., Kari F. W., French J., Leininger J. R., Travlos G., Wilson R., Barrett J. C. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53 deficient mice. Cancer Res. 1997; 57: 4667–4672
- Chan J. M., Stampfer M. J., Giovannucci E., Gann P. H., Ma J., Wilkinson P., Hennekens C. H., Pollak M. Plasma insulin-like growth factor-1 and prostate cancer risk: A prospective study. Science 1998; 279: 563–566
- Tomatis L., Huff J., Hertz-Picciotto I., Sandler D. P., Bucher J., Boffetta P., Axelson O., Blair A., Taylor J., Stayner L., Barrett J. C. Avoided and avoidable risks of cancer. Carcinogenesis 1997; 18: 97–105